Actively Recruiting

Phase Not Applicable
Age: 40Years +
All Genders
NCT07068789

Revascularization of Single Vesrus Multiple Infrapopliteal Vessels in Chronic Limb Threatening Ischemia

Led by Sohag University · Updated on 2025-07-16

40

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This interventional prospective study aims to assess the effectiveness of single vessel versus multiple vessel infrapopliteal angioplasty in patients with chronic threatening limb ischemia . The study compares limb salvage rates and clinical outcomes across two groups over a defined follow up period

CONDITIONS

Official Title

Revascularization of Single Vesrus Multiple Infrapopliteal Vessels in Chronic Limb Threatening Ischemia

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 40 years or older
  • Patients with Rutherford category "4" and "5"
  • Patients with angiographic evidence of infrapopliteal vessel occlusive disease
Not Eligible

You will not qualify if you...

  • Patients who refuse to participate in the study
  • Patients with isolated proximal arterial disease (e.g. superficial femoral artery or popliteal) without infrapopliteal involvement
  • Patients who develop acute thrombosis, flow limiting dissection, or perforation in the infrapopliteal arteries during intervention

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Faculty of Medicine of Sohag

Sohag, Sohag Governorate, Egypt, 82511

Actively Recruiting

Loading map...

Research Team

M

Mahmoud Abdelrahman hafez, Master's student

CONTACT

M

Mahmoud El-saedy, MB BCh ( candidate )

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here